Cambridge Healthtech Institute’s 13th Annual

Patient Engagement, Enrollment and Retention through Communities and Technology  

Patient-Centric Approaches to Participant Engagement and Trial Optimization

February 20-21, 2020


Patient engagement, enrollment planning, patient recruitment, and a more patient-centric approach to study planning and execution are critical to drug development programs and garner a lot of attention by study teams. However, once the hard work of identifying and recruiting a trial subject has been accomplished, they must be retained and remain in compliance. More importantly, industry should be actively listening, engaging and garnering insights from the volunteers who are the foundation and purpose of all of the research. The engagement, continuous exchange of knowledge, retention of patients, and continued engagement throughout the life of a clinical trial is essential to have complete data sets for your analysis and subsequent filings. There are strategies, tools, and data-driven techniques such as social media platforms and mobile technology, empowered patient communities, and a more informed and diverse patient population that need to be understood and engaged. CHI’s 13th Annual “Patient Engagement, Enrollment and Retention through Communities and Technology” will cover the topics one should consider when planning and strategically implementing a patient engagement strategy and retention plan in the digital age.

Arrive early and attend Part 1 (Wed - Thurs): Enrollment Planning and Patient Recruitment

Preliminary Agenda

ENABLE EMPOWERED PATIENTS IN CLINICAL TRIALS BY INTEGRATING THE PATIENT VOICE, HEALTH LITERACY, AND CULTURAL SENSITIVITY

CO-PRESENTATION: Partnering with Patients to Tackle Engagement Together

Leily Saadat-Lajevardi, Senior Manager, OTC Appropriate Use (Patient Education), Johnson & Johnson
Alyson Gregg, MBA, Director, Patient Insights, Janssen

CO-PRESENTATION: Enable Empowered Patients in Clinical Trials by Integrating Health Literacy and Cultural Sensitivity

Laurie Myers, MBA, Global Health Literacy Director, Global Population Health, Merck & Co., Inc.
Alicia Staley, MBA, Cancer Survivor

ACHIEVING NEXT-GEN CONSUMER HEALTH AND RESEARCH THROUGH PATIENT ENGAGEMENT AND DIGITAL TECH

Achieving Next-Gen Consumer Health and Research through Patient Engagement and Digital Tech

Raj Pallapothu, mHealth Global Business Lead, Bayer Pharmaceuticals; mHealth Global Advocate

ACTIVE LISTENING & TECHNOLOGY AS CONDUITS TO IMPROVED PATIENT-FOCUSED CLINICAL DEVELOPMENT

Technology as a Conduit to Patient Focused Clinical Development: The Future is Now

April Lewis, Senior Director, R&D Technology, GSK

CO-PRESENTATION: The Mutual Benefits of Active Listening

Michele Teufel, Patient and Site Engagement Lead, Development Operations, AstraZeneca
John Linnell, Clinical Trial Participant and Member of AZ's Patient Partnership Program

CASE STUDY: Collaborating with Advocacy Organizations to Integrate Patient Perspective into Research

Mary McGowan, Executive Director, The Myositis Association

PARTNERING WITH PATIENT ADVOCACY GROUPS TO IMProve PATIENT ENGAGEMENT ACROSS DRUG DEVELOPMENT

Partnering with Patient Advocacy Groups to Create Meaningful Patient Engagement across the Drug Development Continuum

Christina Román, Senior Community Engagement Manager, Community Partnerships, Cystic Fibrosis Foundation

FACILITATING THE TRIALS OF THE FUTURE NOW VIA THE CONNECTED PATIENT & DECENTRALIZED TRIALS
(SPECIAL SHARED SESSION)

The Connected Patient: A "One Stop Shop" for Trial Information and Data

Megan McBride, MPH, Associate Director, Janssen Clinical Innovation, GCDO, R&D, Janssen, The Pharmaceutical Companies of Johnson & Johnson

INTERACTIVE PANEL: Translating Virtual to Reality: Decentralized Trial Transformation

Moderator: Jane Myles, Head, Operational Intelligence and Innovation, Roche
Bardia Akbari, PharmD, Senior Vice President, Clinical Operations, Science37
FDA Representative to be Confirmed

PLENARY KEYNOTES

Tuesday Evening, Wednesday Morning, Wednesday Afternoon Plenary Keynotes Featuring:

SCOPE’s 2020 Participant Engagement Award, in Memory of Jerry Matczak
Patient Perspectives as an Input to Feasibility and Clinical Trial Design
Digital Trends that Are Changing Clinical Research
Health Literacy Throughout Drug Development – Why It Matters to Pharma and to Patients
Implementing an Innovation Methodology to Accelerate Clinical Trial Innovation within Your Organization

For more details on the Plenary Keynotes: www.scopesummit.com/keynotes
For more details on the Participant Engagement Award: www.scopesummit.com/participant-engagement-award

INTERACTIVE BREAKOUT DISCUSSION GROUPS

Concurrent breakout discussion groups are interactive, guided discussions hosted by a facilitator or set of co-facilitators to discuss some of the key issues presented earlier in the day’s sessions. Delegates will join a table of interest and become an active part of the discussion at hand. Bring your pharma, biotech, CRO, site, hospital or patient perspective to each of the discussions below. To get the most out of this interactive session and format please come prepared to share examples from your work, vet some ideas with your peers, be a part of group interrogation and problem solving, and, most importantly, participate in active idea sharing: www.scopesummit.com/breakouts

 

Arrive early and attend Part 1 (Wed - Thurs): Enrollment Planning and Patient Recruitment




For more details on the conference, please contact:
Micah Lieberman

Executive Director, Conferences

Cambridge Healthtech Institute (CHI)

Phone: (+1) 541. 482.4709
Email: mlieberman@healthtech.com

 

For partnering and sponsorship information, please contact:

Companies A-K

Ilana Quigley

Senior Manager, Business Development

Cambridge Healthtech Institute (CHI)

Phone: (+1) 781.972.5457

Email: iquigley@healthtech.com

 

Companies L-Z

Patty Rose
Senior Manager, Business Development

Cambridge Healthtech Institute (CHI)

Phone: (+1) 781.972.1349
Email: prose@healthtech.com